Podorbit
DiscoverPodcastsGuestsCompanies
Podorbit

Tech podcasts · indexed by guest & company

PrivacyTermsSupport
support@podorbit.app
Flagship Pioneering

Flagship Pioneering

flagshippioneering.com →

People from Flagship Pioneering

Noubar Afeyan
Noubar Afeyan

Co-founder and Chairman

Episodes featuring Flagship Pioneering (3)

No Priors: Artificial Intelligence | Technology | Startups/Oct 31, 2025/19m

The Best of 2025 (So Far) with Sarah Guo and Elad Gil

2025 has thus far been a year of great leaps and advances in AI technology. And Sarah and Elad have spoken with some of the most enterprising founders and scientific minds in the field of AI today. So we’re revisiting a few of our favorite conversations on No Priors so far in 2025 – Winston Weinberg (Harvey), Dr. Fei-Fei Li (World Labs), Brendan Foody (Mercor), Dan Hendrycks (Center for AI Safety), Noubar Afeyan (Flagship Pioneering), Brandon McKinzie and Eric Mitchell (OpenAI o3), Isa Fulford (OpenAI), Arvind Jain (Glen), and Dr. Shiv Rao (Abridge).  Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil  Chapters: 00:00 – Episode Introduction 0:21 – Winston Weinberg on Leaning into New Capabilities 02:01 – Dr. Fei-Fei Li on Spatial Intelligence 04:13 – Brendan Foody on AI Disruption in the Workforce 06:10 – Dan Hendrycks on the Geopolitics of Superintelligence 08:06 – Noubar Afeyan on Entrepreneurship   10:38 – Brandon McKinzie and Eric Mitchell on Reasoning Models 12:41 – Isa Fulford on Training Deep Research 13:49 – Arvind Jain on Innovating Enterprise Search 16:21 – Dr. Shiv Rao on AI’s Human Impact 18:58 – Conclusion

Winston Weinberg

Co-Founder and CEO

HarveyHarvey
Fei-Fei Li
Fei-Fei Li

Co-Founder and CEO

World LabsWorld LabsStanford UniversityStanford UniversityStanford Institute for Human-Centered Artificial IntelligenceStanford Institute for Human-Centered Artificial IntelligenceStanford Human-Centered AI InstituteStanford Human-Centered AI InstituteStanford University HAIStanford University HAI
Brendan Foody

Co-Founder and CEO

MercorMercor
Dan Hendrycks

Director

Center for AI SafetyCenter for AI Safety
Noubar Afeyan
Noubar Afeyan

Founder and CEO

Flagship PioneeringFlagship PioneeringModernaModerna
Brandon McKinzie

Researcher

OpenAIOpenAI
Eric Mitchell

Researcher

OpenAIOpenAI
Isa Fulford

Researcher

OpenAIOpenAI
Arvind Jain

Founder and CEO

GleanGlean
Shiv Rao

Co-Founder and CEO

AbridgeAbridge
No Priors: Artificial Intelligence | Technology | Startups/Feb 27, 2025/41m

Building the Platform for Scientific Breakthrough, with Noubar Afeyan of Moderna and Flagship Pioneering

This week on No Priors, Sarah sits down with Noubar Afeyan, Co-founder and CEO of Flagship Pioneering, the biotech firm behind groundbreaking companies like Moderna. They explore how Flagship creates the conditions for scientific breakthroughs, tackles regulatory uncertainty, and pushes the boundaries of discovery. Noubar shares insights on AI’s role in healthcare, the challenges of bringing new therapies to market, and lessons learned from past pandemics. He also discusses Flagship’s platform approach to biotech innovation and introduces the idea of polyintelligence. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @NoubarAfeyan Show Notes:  0:00 Introduction 0:48 Founding Flagship  5:51 Fostering environments for emergence 11:17 Expanding into new frontiers 14:26 Developing technology amid regulatory uncertainty and risk 19:12 How Flagship has evolved 22:47 AI applications in healthcare 27:30 Bottlenecks in bringing new therapies to market 32:20 Lessons for the next pandemic 34:11 Building a platform 38:10 Polyintelligence

Noubar Afeyan
Noubar Afeyan

Founder and CEO

Flagship PioneeringFlagship PioneeringModernaModerna
How I Built This with Guy Raz/Oct 11, 2021/1h 6m

Moderna and Flagship Pioneering: Noubar Afeyan

In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a way to deploy the messenger RNA molecule to tackle life-threatening diseases. In January of 2020, an urgent opportunity presented itself in the form of a deadly virus that was spreading across the globe. At a breathtaking pace, Moderna produced a prototype for a COVID-19 vaccine, partnered with the NIH to test it, and produced millions of doses, becoming part of the most rapid vaccine roll-out in human history. While Moderna is the best known of Noubar's companies, he has launched many others in the bio-tech space as part of Flagship Pioneering, his multi-billion dollar venture studio. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Noubar Afeyan
Noubar Afeyan

Founder and CEO

Flagship PioneeringFlagship PioneeringModernaModerna